» Articles » PMID: 33306739

Distinct Polymorphisms in a Single Herpesvirus Gene Are Capable of Enhancing Virulence and Mediating Vaccinal Resistance

Overview
Journal PLoS Pathog
Specialty Microbiology
Date 2020 Dec 11
PMID 33306739
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Modified-live herpesvirus vaccines are widely used in humans and animals, but field strains can emerge that have a higher virulence and break vaccinal protection. Since the introduction of the first vaccine in the 1970s, Marek's disease virus overcame the vaccine barrier by the acquisition of numerous genomic mutations. However, the evolutionary adaptations in the herpesvirus genome responsible for the vaccine breaks have remained elusive. Here, we demonstrate that point mutations in the multifunctional meq gene acquired during evolution can significantly alter virulence. Defined mutations found in highly virulent strains also allowed the virus to overcome innate cellular responses and vaccinal protection. Concomitantly, the adaptations in meq enhanced virus shedding into the environment, likely providing a selective advantage for the virus. Our study provides the first experimental evidence that few point mutations in a single herpesviral gene result in drastically increased virulence, enhanced shedding, and escape from vaccinal protection.

Citing Articles

Marek's Disease Virus (MDV) Meq Oncoprotein Plays Distinct Roles in Tumor Incidence, Distribution, and Size.

Ajithdoss D, Liao Y, Reddy S, Lupiani B Viruses. 2025; 17(2).

PMID: 40007015 PMC: 11860637. DOI: 10.3390/v17020259.


High-Fidelity Long-Read Sequencing of an Avian Herpesvirus Reveals Extensive Intrapopulation Diversity in Tandem Repeat Regions.

Ortigas-Vasquez A, Bowen C, Renner D, Baigent S, Zhang Y, Yao Y bioRxiv. 2025; .

PMID: 39990410 PMC: 11844383. DOI: 10.1101/2025.02.10.637388.


The Genes of Nigerian Marek's Disease Virus (MDV) Field Isolates Contain Mutations Common to Both European and US High Virulence Strains.

Patria J, Jwander L, Mbachu I, Parcells L, Ladman B, Trimpert J Viruses. 2025; 17(1).

PMID: 39861844 PMC: 11769123. DOI: 10.3390/v17010056.


Telomeric repeats in the commercial SB-1 vaccine facilitate viral integration and contribute to vaccine efficacy.

You Y, Kheimar A, Vychodil T, Kossak L, Sabsabi M, Conradie A NPJ Vaccines. 2024; 9(1):154.

PMID: 39169010 PMC: 11339279. DOI: 10.1038/s41541-024-00945-6.


Immune escape of avian oncogenic Marek's disease herpesvirus and antagonistic host immune responses.

Zhu Z, Teng M, Liu Y, Chen F, Yao Y, Li E NPJ Vaccines. 2024; 9(1):109.

PMID: 38879650 PMC: 11180173. DOI: 10.1038/s41541-024-00905-0.


References
1.
Tischer B, von Einem J, Kaufer B, Osterrieder N . Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli. Biotechniques. 2006; 40(2):191-7. DOI: 10.2144/000112096. View

2.
Bertzbach L, Pfaff F, Pauker V, Kheimar A, Hoper D, Hartle S . The Transcriptional Landscape of Marek's Disease Virus in Primary Chicken B Cells Reveals Novel Splice Variants and Genes. Viruses. 2019; 11(3). PMC: 6466439. DOI: 10.3390/v11030264. View

3.
Andre F, Booy R, Bock H, Clemens J, Datta S, John T . Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ. 2008; 86(2):140-6. PMC: 2647387. DOI: 10.2471/blt.07.040089. View

4.
Murata S, Okada T, Kano R, Hayashi Y, Hashiguchi T, Onuma M . Analysis of transcriptional activities of the Meq proteins present in highly virulent Marek's disease virus strains, RB1B and Md5. Virus Genes. 2011; 43(1):66-71. DOI: 10.1007/s11262-011-0612-x. View

5.
Tischer B, Kaufer B . Viral bacterial artificial chromosomes: generation, mutagenesis, and removal of mini-F sequences. J Biomed Biotechnol. 2012; 2012:472537. PMC: 3303620. DOI: 10.1155/2012/472537. View